Product NDC: | 64980-141 |
Proprietary Name: | ALPRAZOLAM EXTENDED-RELEASE |
Non Proprietary Name: | ALPRAZOLAM |
Active Ingredient(s): | 1 mg/1 & nbsp; ALPRAZOLAM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64980-141 |
Labeler Name: | Rising Pharmaceuticals Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077996 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070328 |
Package NDC: | 64980-141-10 |
Package Description: | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64980-141-10) |
NDC Code | 64980-141-10 |
Proprietary Name | ALPRAZOLAM EXTENDED-RELEASE |
Package Description | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64980-141-10) |
Product NDC | 64980-141 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ALPRAZOLAM |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20070328 |
Marketing Category Name | ANDA |
Labeler Name | Rising Pharmaceuticals Inc |
Substance Name | ALPRAZOLAM |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |